You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dimethyl Fumarate

Showing 1 - 25 of 648
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intracranial Aneurysm, Aneurysm, Brain, Inflammation Vascular Trial in Beijing (Dimethyl fumarate, Placebo)

Not yet recruiting
  • Intracranial Aneurysm
  • +2 more
  • Dimethyl fumarate
  • Placebo
  • Beijing, Beijing, China
    Beijing Neurosurgical Institute & Beijing Tiantan Hospital
Jul 16, 2023

Brain Abnormalities in Multiple Sclerosis.

Recruiting
  • Multiple Sclerosis
  • Dimethyl Fumarate 240 MG [Tecfidera]
  • Messina, Italy
    IRCCS Centro Neurolesi "Bonino-Pulejo"
Mar 31, 2023

Relapsing Remitting Multiple Sclerosis Trial (monomethyl fumarate 190 mg, dimethyl fumarate 240 mg)

Completed
Has Results
  • Relapsing Remitting Multiple Sclerosis
  • monomethyl fumarate 190 mg
  • dimethyl fumarate 240 mg
  • (no location specified)
Dec 5, 2022

Multiple Sclerosis Trial (Dimethyl fumarate)

Not yet recruiting
  • Multiple Sclerosis
  • Dimethyl fumarate
  • (no location specified)
Dec 12, 2022

Age-related Macular Degeneration (AMD) Trial in Créteil (Dimethyl Fumarate (TECFIDERA™), No active : no treatment)

Recruiting
  • Age-related Macular Degeneration (AMD)
  • Dimethyl Fumarate (TECFIDERA™)
  • No active : no treatment
  • Créteil, Val De Marne, France
    Centre intercommunal de Créteil
Aug 2, 2022

Multiple Sclerosis Trial (Diroximel Fumarate, Avonex, Tysabri)

Not yet recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +3 more
  • (no location specified)
Dec 12, 2022

Systemic Sclerosis, Pulmonary; Hypertension Trial in United States (Dimethyl Fumarate (DMF), Placebo Oral Tablet)

Terminated
Has Results
  • Systemic Sclerosis
  • Pulmonary; Hypertension
  • Dimethyl Fumarate (DMF)
  • Placebo Oral Tablet
  • Denver, Colorado
  • +3 more
Mar 15, 2022

Relationship Between Oral DMT Burden and Adherence in MS

Enrolling by invitation
  • Multiple Sclerosis
  • Adherence, Medication
  • Melbourne, Victoria, Australia
    Monash University
Aug 28, 2022

Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam®

Withdrawn
  • Relapsing Remitting Multiple Sclerosis
  • monomethyl fumarate
  • (no location specified)
Nov 15, 2021

Long-Term Safety of Vumerity and Tecfidera in Multiple Sclerosis

Not yet recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +2 more
  • (no location specified)
Mar 2, 2023

Czech Pharmaco-epidemiological Study on Disease Modifying Drugs

Completed
  • Multiple Sclerosis
  • interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
  • Prague, Czechia
    IMPULS Endowment Fund
Mar 7, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Dimethyl Fumarate, Peginterferon Beta-1a, Placebo)

Terminated
  • Multiple Sclerosis, Relapsing-Remitting
  • Dimethyl Fumarate
  • +2 more
  • Raleigh, North Carolina
  • +22 more
Nov 30, 2022

Intracerebral Hemorrhage Trial in Beijing (Dimethyl fumarate, Placebo)

Not yet recruiting
  • Intracerebral Hemorrhage
  • Dimethyl fumarate
  • Placebo
  • Beijing, Beijing, China
    Xuanwu Hospital, Beijing
May 17, 2021

Acute Ischemic Stroke Trial (Dimethyl fumarate, Placebo)

Not yet recruiting
  • Acute Ischemic Stroke
  • Dimethyl fumarate
  • Placebo
  • (no location specified)
May 17, 2021

Acute Ischemic Stroke Trial (Dimethyl Fumarate, Placebo)

Not yet recruiting
  • Acute Ischemic Stroke
  • Dimethyl Fumarate
  • Placebo
  • (no location specified)
May 17, 2021

Tecfidera Capsules in Korean Relapsing-Remitting Multiple

Completed
  • Multiple Sclerosis, Relapsing-remitting
  • No Intervention
  • Cheonan, Chungcheongnam-do, Korea, Republic of
  • +19 more
May 4, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Sweden (Rituximab, Dimethyl fumarate, Sodium Chloride solution)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • Borås, Sweden
  • +16 more
Oct 11, 2021

Generic Delayed-Release Dimethyl Fumarate in Routine Medical

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • Dimethyl Fumarate (DMF)
  • Blida, Algeria
  • +5 more
Sep 1, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in Norway (dimethyl fumarate, injectable MS DMT)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • dimethyl fumarate
  • injectable MS DMT
  • Drammen, Norway
  • +6 more
Sep 3, 2021

Assess Resource Utilization and Quality of Life of RRMS Treated

Completed
  • RRMS
  • Dimethyl Fumarate (DMF)
  • Thessaloniki, Greece
    University General Hospital AHEPA (B')
Jul 27, 2021

Primary Progressive Multiple Sclerosis Trial in Copenhagen (Dimethyl fumarate, Placebo)

Completed
  • Primary Progressive Multiple Sclerosis
  • Dimethyl fumarate
  • Placebo
  • Copenhagen, Denmark
    Danish Multiple Sclerosis Center, Department of neurology
Dec 22, 2020

Relapsing-remitting Multiple Sclerosis Trial in Stockholm (Rituximab)

Active, not recruiting
  • Relapsing-remitting Multiple Sclerosis
  • Stockholm, Sweden
    Fredrik Piehl
Apr 8, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Chisinau, Moldova, Republic of
    Republican Clinical Hospital, ARENSIA Exploratory Medicine
Jun 8, 2022

Dimethyl Fumarate Persistence in RR-MS Patients Included in

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Dimethyl Fumarate
  • PSP
  • Agen, France
  • +80 more
Mar 28, 2022

Teriflunomide Tecfidera LMCE

Completed
  • Tecfidera
  • Teriflunomide
  • Buffalo, New York
    Buffalo Neuroimaging Analysis Center
Jan 4, 2021